Star Source Multi Trade P/B Ratio
STARSOURCE • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
10.98
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
10.98
Current Price
₹82.50
Book Value/Share
₹20.00
Exchange
BSE
Book Value Breakdown (2016)
Balance Sheet Components
Total Equity
₹4 Cr
Share Capital
₹2 Cr
Reserves & Surplus
₹2 Cr
Outstanding Shares
2,000,000
Book Value per Share
₹20.00
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-0.16
Sector Median
0.63
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Star Source Multi Trade
- Stock appears overvalued with PB of 10.98, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.16
View the current stock price of Star Source Multi Trade for more insights.
Related Pages for Star Source Multi Trade
Additional stock information and data for STARSOURCE
Sector P/B Ratio Comparison
Comparing Star Source Multi Trade with other companies in Healthcare sector
Sector Average
-0.16
Sector Median
0.63
Lowest P/B
-12.06
Highest P/B
1.09
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.06 | ₹4,124 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |